Type I [4σ+4π] versus [4σ+4π−1] Cycloaddition To Access Medium‐Sized Carbocycles and Discovery of a Liver X Receptor β‐Selective Ligand

Author:

Jiang Cheng1,Hu Lingfei2,Shen Shuna1,Zhang Jianyu1,Wang Xi1,Ma Dongxu1,Lu Gang2,Xu Tao1ORCID

Affiliation:

1. Molecular Synthesis Center & Key Laboratory of Marine Drugs Ministry of Education; School of Medicine and Pharmacy Laboratory for Marine Drugs and Bioproducts of Marine Natural Products Ocean University of China 5 Yushan road Qingdao 266003 China

2. School of Chemistry and Chemical Engineering Key Laboratory of Colloid and Interface Chemistry Ministry of Education Shandong University 27 Shandanan road Jinan 250100 China

Abstract

AbstractTransition‐metal‐catalyzed [4+4] cycloaddition leading to cyclooctanoids has centered on dimerization between 1,3‐diene‐type substrates. Herein, we describe a [4σ+4π−1] and [4σ+4π] cycloaddition strategy to access 7/8‐membered fused carbocycles through rhodium‐catalyzed coupling between the 4σ‐donor (benzocyclobutenones) and pendant diene (4π) motifs. The two pathways can be controlled by adjusting the solvated CO concentration. A broad range (>40 examples) of 5–6–7 and 5–6–8 polyfused carbocycles was obtained in good yields (up to 90 %). DFT calculations, kinetic monitoring and 13C‐labeling experiments were carried out, suggesting a plausible mechanism. Notably, one 5–6–7 tricycle was found to be a very rare, potent, and selective ligand for the liver X receptor β (KD=0.64 μM), which is a potential therapeutic target for cholesterol‐metabolism‐related fatal diseases.

Publisher

Wiley

Reference99 articles.

1. For isolation and drug development of the selected natural products in Figure  for taxol:

2. M. Suffness Taxol: Science and Applications; CRC Press: Boca Raton FL 1995. For pleuromutilin:

3. Pleuromutilin and its Derivatives-The Lead Compounds for Novel Antibiotics

4. Efficient Antibacterial Agents: A Review of the Synthesis, Biological Evaluation and Mechanism of Pleuromutilin Derivatives

5. Antibacterial properties and clinical potential of pleuromutilins

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3